All In MedTech

Device Trial Radar · NCT05404880

INSPIRIS China PMCF Study

Post-Market Clinical Follow-up Study of Edwards Lifesciences INSPIRIS RESILIA Aortic Valve in Chinese Population

Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

255

Actual

Start

Jul 13, 2022

Primary completion

Mar 2034

Study completion Dec 2034

Sponsor

Lead sponsor
Edwards LifesciencesPublic (EW)
Sponsor type
Industry
Collaborators
Edwards (Shanghai) Lifesciences Medical Supplies Co., Ltd.; Rundo International Pharmaceutical Research & Development Co.,Ltd.; Chinese Academy of Medical Sciences, Fuwai Hospital
First posted
Jun 3, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this post-market trial is to evaluate long term safety and performance of the Edwards Lifesciences INSPIRIS RESILIA aortic valve in Chinese patients in a real-world clinical setting.

Conditions

  • Aortic Valve Replacement

Interventions

  • EDWARDS INSPIRIS RESILIA Aortic ValveDevice

    Surgical replacement of the aortic valve with the INSPIRIS RESILIA Aortic Valve.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subject's Occurrence Rate of Study Valve Related DeathTime frame: 10 Years
  2. Subject's Occurrence Rate of Structural Valve DeteriorationTime frame: 10 Years
  3. Subject's Occurrence Rate of Re-operation on the Study ValveTime frame: 10 Years

5 more outcomes with a free account

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Anzhen Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Fuwai Hospital, CAMS & PUMC

    Beijing, Beijing Municipality, China

  • Xiamen Cardiovascular Hospital Xiamen University

    Xiamen, Fujian, China

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.